Skip to main content
Top
Published in: Diabetologia 1/2016

Open Access 01-01-2016 | Article

Prospective associations between sedentary time, physical activity, fitness and cardiometabolic risk factors in people with type 2 diabetes

Authors: Maxine J. E. Lamb, Kate Westgate, Søren Brage, Ulf Ekelund, Gráinne H. Long, Simon J. Griffin, Rebecca K. Simmons, Andrew J. M. Cooper, on behalf of the ADDITION-Plus study team

Published in: Diabetologia | Issue 1/2016

Login to get access

Abstract

Aims/hypothesis

The aim of this study was to examine the prospective associations between objectively measured physical activity energy expenditure (PAEE), sedentary time, moderate-to-vigorous-intensity physical activity (MVPA), cardiorespiratory fitness (CRF) and cardiometabolic risk factors over 4 years in individuals with recently diagnosed diabetes.

Methods

Among 308 adults (mean age 61.0 [SD 7.2] years; 34% female) with type 2 diabetes from the Anglo–Danish–Dutch Study of Intensive Treatment in People with Screen Detected Diabetes in Primary Care (ADDITION)-Plus study, we measured physical activity using individually calibrated combined heart rate and movement sensing. Multivariable linear regression models were constructed to examine the associations between baseline PAEE, sedentary time, MVPA, CRF and cardiometabolic risk factors and clustered cardiometabolic risk (CCMR) at follow-up, and change in these exposures and change in CCMR and its components over 4 years of follow-up.

Results

Individuals who increased their PAEE between baseline and follow-up had a greater reduction in waist circumference (−2.84 cm, 95% CI −4.84, −0.85) and CCMR (−0.17, 95% CI −0.29, −0.04) compared with those who decreased their PAEE. Compared with individuals who decreased their sedentary time, those who increased their sedentary time had a greater increase in waist circumference (3.20 cm, 95% CI 0.84, 5.56). Increases in MVPA were associated with reductions in systolic blood pressure (−6.30 mmHg, 95% CI −11.58, −1.03), while increases in CRF were associated with reductions in CCMR (−0.23, 95% CI −0.40,−0.05) and waist circumference (−3.79 cm, 95% CI −6.62, −0.96). Baseline measures were generally not predictive of cardiometabolic risk at follow-up.

Conclusions/interpretation

Encouraging people with recently diagnosed diabetes to increase their physical activity and decrease their sedentary time may have beneficial effects on their waist circumference, blood pressure and CCMR.
Literature
1.
go back to reference Hu FB, Stampfer MJ, Solomon CG et al (2001) The impact of diabetes mellitus on mortality from all causes and coronary heart disease in women: 20 years of follow-up. Arch Intern Med 161:1717–1723CrossRefPubMed Hu FB, Stampfer MJ, Solomon CG et al (2001) The impact of diabetes mellitus on mortality from all causes and coronary heart disease in women: 20 years of follow-up. Arch Intern Med 161:1717–1723CrossRefPubMed
2.
go back to reference Lotufo PA, Gaziano JM, Chae CU et al (2001) Diabetes and all-cause and coronary heart disease mortality among US male physicians. Arch Intern Med 161:242–247CrossRefPubMed Lotufo PA, Gaziano JM, Chae CU et al (2001) Diabetes and all-cause and coronary heart disease mortality among US male physicians. Arch Intern Med 161:242–247CrossRefPubMed
3.
go back to reference Fox CS, Coady S, Sorlie PD et al (2004) Trends in cardiovascular complications of diabetes. JAMA 292:2495–2499CrossRefPubMed Fox CS, Coady S, Sorlie PD et al (2004) Trends in cardiovascular complications of diabetes. JAMA 292:2495–2499CrossRefPubMed
4.
go back to reference Jeon CY, Lokken RP, Hu FB, van Dam RM (2007) Physical activity of moderate intensity and risk of type 2 diabetes: a systematic review. Diabetes Care 30:744–752CrossRefPubMed Jeon CY, Lokken RP, Hu FB, van Dam RM (2007) Physical activity of moderate intensity and risk of type 2 diabetes: a systematic review. Diabetes Care 30:744–752CrossRefPubMed
5.
go back to reference Colberg SR, Sigal RJ, Fernhall B et al (2010) Exercise and type 2 diabetes: the American College of Sports Medicine and the American Diabetes Association: joint position statement executive summary. Diabetes Care 33:2692–2696PubMedCentralCrossRefPubMed Colberg SR, Sigal RJ, Fernhall B et al (2010) Exercise and type 2 diabetes: the American College of Sports Medicine and the American Diabetes Association: joint position statement executive summary. Diabetes Care 33:2692–2696PubMedCentralCrossRefPubMed
6.
go back to reference Morrato EH, Hill JO, Wyatt HR et al (2007) Physical activity in U.S. adults with diabetes and at risk for developing diabetes, 2003. Diabetes Care 30:203–209CrossRefPubMed Morrato EH, Hill JO, Wyatt HR et al (2007) Physical activity in U.S. adults with diabetes and at risk for developing diabetes, 2003. Diabetes Care 30:203–209CrossRefPubMed
7.
go back to reference Jakicic JM, Gregg E, Knowler W et al (2010) Activity patterns of obese adults with type 2 diabetes in the look AHEAD study. Med Sci Sports Exerc 42:1995–2005PubMedCentralCrossRefPubMed Jakicic JM, Gregg E, Knowler W et al (2010) Activity patterns of obese adults with type 2 diabetes in the look AHEAD study. Med Sci Sports Exerc 42:1995–2005PubMedCentralCrossRefPubMed
8.
go back to reference Wilmot EG, Davies MJ, Edwardson CL et al (2011) Rationale and study design for a randomised controlled trial to reduce sedentary time in adults at risk of type 2 diabetes mellitus: project stand (Sedentary Time ANd diabetes). BMC Public Health 11:908PubMedCentralCrossRefPubMed Wilmot EG, Davies MJ, Edwardson CL et al (2011) Rationale and study design for a randomised controlled trial to reduce sedentary time in adults at risk of type 2 diabetes mellitus: project stand (Sedentary Time ANd diabetes). BMC Public Health 11:908PubMedCentralCrossRefPubMed
9.
go back to reference Healy GN, Wijndaele K, Dunstan DW et al (2008) Objectively measured sedentary time, physical activity, and metabolic risk: the Australian Diabetes, Obesity and Lifestyle Study (AusDiab). Diabetes Care 31:369–371CrossRefPubMed Healy GN, Wijndaele K, Dunstan DW et al (2008) Objectively measured sedentary time, physical activity, and metabolic risk: the Australian Diabetes, Obesity and Lifestyle Study (AusDiab). Diabetes Care 31:369–371CrossRefPubMed
10.
11.
go back to reference Henson J, Yates T, Biddle SJH et al (2013) Associations of objectively measured sedentary behaviour and physical activity with markers of cardiometabolic health. Diabetologia 56:1012–1020CrossRefPubMed Henson J, Yates T, Biddle SJH et al (2013) Associations of objectively measured sedentary behaviour and physical activity with markers of cardiometabolic health. Diabetologia 56:1012–1020CrossRefPubMed
12.
go back to reference Kim J, Tanabe K, Yokoyama N et al (2013) Objectively measured light-intensity lifestyle activity and sedentary time are independently associated with metabolic syndrome: a cross-sectional study of Japanese adults. Int J Behav Nutr Phys Act 10:30PubMedCentralCrossRefPubMed Kim J, Tanabe K, Yokoyama N et al (2013) Objectively measured light-intensity lifestyle activity and sedentary time are independently associated with metabolic syndrome: a cross-sectional study of Japanese adults. Int J Behav Nutr Phys Act 10:30PubMedCentralCrossRefPubMed
13.
go back to reference Ekelund U, Brage S, Griffin SJ et al (2009) Objectively measured moderate- and vigorous-intensity physical activity but not sedentary time predicts insulin resistance in high-risk individuals. Diabetes Care 32:1081–1086PubMedCentralCrossRefPubMed Ekelund U, Brage S, Griffin SJ et al (2009) Objectively measured moderate- and vigorous-intensity physical activity but not sedentary time predicts insulin resistance in high-risk individuals. Diabetes Care 32:1081–1086PubMedCentralCrossRefPubMed
14.
go back to reference Scheers T, Philippaerts R, Lefevre J (2013) SenseWear-determined physical activity and sedentary behavior and metabolic syndrome. Med Sci Sports Exerc 45:481–489CrossRefPubMed Scheers T, Philippaerts R, Lefevre J (2013) SenseWear-determined physical activity and sedentary behavior and metabolic syndrome. Med Sci Sports Exerc 45:481–489CrossRefPubMed
15.
go back to reference Ekelund U, Franks PW, Sharp S et al (2007) Increase in physical activity energy expenditure is associated with reduced metabolic risk independent of change in fatness and fitness. Diabetes Care 30:2101–2106CrossRefPubMed Ekelund U, Franks PW, Sharp S et al (2007) Increase in physical activity energy expenditure is associated with reduced metabolic risk independent of change in fatness and fitness. Diabetes Care 30:2101–2106CrossRefPubMed
16.
go back to reference Griffin SJ, Simmons RK, Williams KM et al (2011) Protocol for the ADDITION-Plus study: a randomised controlled trial of an individually-tailored behaviour change intervention among people with recently diagnosed type 2 diabetes under intensive UK general practice care. BMC Public Health 11:211PubMedCentralCrossRefPubMed Griffin SJ, Simmons RK, Williams KM et al (2011) Protocol for the ADDITION-Plus study: a randomised controlled trial of an individually-tailored behaviour change intervention among people with recently diagnosed type 2 diabetes under intensive UK general practice care. BMC Public Health 11:211PubMedCentralCrossRefPubMed
17.
go back to reference Echouffo-Tcheugui JB, Simmons RK, Williams KM et al (2009) The ADDITION-Cambridge trial protocol: a cluster—randomised controlled trial of screening for type 2 diabetes and intensive treatment for screen-detected patients. BMC Public Health 9:136PubMedCentralCrossRefPubMed Echouffo-Tcheugui JB, Simmons RK, Williams KM et al (2009) The ADDITION-Cambridge trial protocol: a cluster—randomised controlled trial of screening for type 2 diabetes and intensive treatment for screen-detected patients. BMC Public Health 9:136PubMedCentralCrossRefPubMed
18.
go back to reference Griffin SJ, Simmons RK, Prevost AT et al (2014) Multiple behaviour change intervention and outcomes in recently diagnosed type 2 diabetes: the ADDITION-Plus randomised controlled trial. Diabetologia 57:1308–1319PubMedCentralCrossRefPubMed Griffin SJ, Simmons RK, Prevost AT et al (2014) Multiple behaviour change intervention and outcomes in recently diagnosed type 2 diabetes: the ADDITION-Plus randomised controlled trial. Diabetologia 57:1308–1319PubMedCentralCrossRefPubMed
19.
go back to reference Brage S, Brage N, Franks PW et al (2005) Reliability and validity of the combined heart rate and movement sensor Actiheart. Eur J Clin Nutr 59:561–570CrossRefPubMed Brage S, Brage N, Franks PW et al (2005) Reliability and validity of the combined heart rate and movement sensor Actiheart. Eur J Clin Nutr 59:561–570CrossRefPubMed
20.
go back to reference Brage S, Ekelund U, Brage N et al (2007) Hierarchy of individual calibration levels for heart rate and accelerometry to measure physical activity. J Appl Physiol 103:682–692CrossRefPubMed Brage S, Ekelund U, Brage N et al (2007) Hierarchy of individual calibration levels for heart rate and accelerometry to measure physical activity. J Appl Physiol 103:682–692CrossRefPubMed
21.
go back to reference Tanaka H, Monahan KD, Seals DR (2001) Age-predicted maximal heart rate revisited. J Am Coll Cardiol 37:153–156CrossRefPubMed Tanaka H, Monahan KD, Seals DR (2001) Age-predicted maximal heart rate revisited. J Am Coll Cardiol 37:153–156CrossRefPubMed
22.
go back to reference Stegle O, Fallert SV, MacKay DJC, Brage S (2008) Gaussian process robust regression for noisy heart rate data. IEEE Trans Biomed Eng 55:2143–2151CrossRefPubMed Stegle O, Fallert SV, MacKay DJC, Brage S (2008) Gaussian process robust regression for noisy heart rate data. IEEE Trans Biomed Eng 55:2143–2151CrossRefPubMed
23.
go back to reference Brage S, Brage N, Franks PW et al (2004) Branched equation modeling of simultaneous accelerometry and heart rate monitoring improves estimate of directly measured physical activity energy expenditure. J Appl Physiol 96:343–351CrossRefPubMed Brage S, Brage N, Franks PW et al (2004) Branched equation modeling of simultaneous accelerometry and heart rate monitoring improves estimate of directly measured physical activity energy expenditure. J Appl Physiol 96:343–351CrossRefPubMed
24.
go back to reference Sedentary Behaviour Research N (2012) Letter to the editor: standardized use of the terms “sedentary” and “sedentary behaviours.”. Appl Physiol Nutr Metab 37:540–542CrossRef Sedentary Behaviour Research N (2012) Letter to the editor: standardized use of the terms “sedentary” and “sedentary behaviours.”. Appl Physiol Nutr Metab 37:540–542CrossRef
25.
go back to reference Henry CJ (2005) Basal metabolic rate studies in humans: measurement and development of new equations. Public Health Nutr 8:1133–1152CrossRefPubMed Henry CJ (2005) Basal metabolic rate studies in humans: measurement and development of new equations. Public Health Nutr 8:1133–1152CrossRefPubMed
26.
go back to reference Bingham S, Gill C, Welch A et al (1997) Validation of dietary assessment methods in the UK arm of EPIC using weighed records, and 24-hour urinary nitrogen and potassium and serum vitamin C and carotenoids as biomarkers. Int J Epidemiol 26:137S–151SCrossRef Bingham S, Gill C, Welch A et al (1997) Validation of dietary assessment methods in the UK arm of EPIC using weighed records, and 24-hour urinary nitrogen and potassium and serum vitamin C and carotenoids as biomarkers. Int J Epidemiol 26:137S–151SCrossRef
27.
go back to reference Ryde GC, Gilson ND, Suppini A, Brown WJ (2012) Validation of a novel, objective measure of occupational sitting. J Occup Health 54:383–386CrossRefPubMed Ryde GC, Gilson ND, Suppini A, Brown WJ (2012) Validation of a novel, objective measure of occupational sitting. J Occup Health 54:383–386CrossRefPubMed
28.
go back to reference Hamilton MT, Hamilton DG, Zderic TW (2007) Role of low energy expenditure and sitting in obesity, metabolic syndrome, type 2 diabetes, and cardiovascular disease. Diabetes 56:2655–2667CrossRefPubMed Hamilton MT, Hamilton DG, Zderic TW (2007) Role of low energy expenditure and sitting in obesity, metabolic syndrome, type 2 diabetes, and cardiovascular disease. Diabetes 56:2655–2667CrossRefPubMed
29.
go back to reference Cooper AR, Sebire S, Montgomery AA et al (2012) Sedentary time, breaks in sedentary time and metabolic variables in people with newly diagnosed type 2 diabetes. Diabetologia 55:589–599CrossRefPubMed Cooper AR, Sebire S, Montgomery AA et al (2012) Sedentary time, breaks in sedentary time and metabolic variables in people with newly diagnosed type 2 diabetes. Diabetologia 55:589–599CrossRefPubMed
30.
go back to reference Hansen A-LS, Carstensen B, Helge JW et al (2013) Combined heart rate- and accelerometer-assessed physical activity energy expenditure and associations with glucose homeostasis markers in a population at high risk of developing diabetes: the ADDITION-PRO study. Diabetes Care 36:3062–3069PubMedCentralCrossRefPubMed Hansen A-LS, Carstensen B, Helge JW et al (2013) Combined heart rate- and accelerometer-assessed physical activity energy expenditure and associations with glucose homeostasis markers in a population at high risk of developing diabetes: the ADDITION-PRO study. Diabetes Care 36:3062–3069PubMedCentralCrossRefPubMed
31.
go back to reference Clarke J, Janssen I (2013) Is the frequency of weekly moderate-to-vigorous physical activity associated with the metabolic syndrome in Canadian adults? Appl Physiol Nutr Metab 38:773–778CrossRefPubMed Clarke J, Janssen I (2013) Is the frequency of weekly moderate-to-vigorous physical activity associated with the metabolic syndrome in Canadian adults? Appl Physiol Nutr Metab 38:773–778CrossRefPubMed
32.
go back to reference Ekelund U, Griffin SJ, Wareham NJ (2007) Physical activity and metabolic risk in individuals with a family history of type 2 diabetes. Diabetes Care 30:337–342CrossRefPubMed Ekelund U, Griffin SJ, Wareham NJ (2007) Physical activity and metabolic risk in individuals with a family history of type 2 diabetes. Diabetes Care 30:337–342CrossRefPubMed
33.
go back to reference Cooper AJM, Brage S, Ekelund U et al (2014) Association between objectively assessed sedentary time and physical activity with metabolic risk factors among people with recently diagnosed type 2 diabetes. Diabetologia 57:73–82PubMedCentralCrossRefPubMed Cooper AJM, Brage S, Ekelund U et al (2014) Association between objectively assessed sedentary time and physical activity with metabolic risk factors among people with recently diagnosed type 2 diabetes. Diabetologia 57:73–82PubMedCentralCrossRefPubMed
34.
go back to reference Simmons RK, Griffin SJ, Steele R et al (2008) Increasing overall physical activity and aerobic fitness is associated with improvements in metabolic risk: cohort analysis of the ProActive trial. Diabetologia 51:787–794PubMedCentralCrossRefPubMed Simmons RK, Griffin SJ, Steele R et al (2008) Increasing overall physical activity and aerobic fitness is associated with improvements in metabolic risk: cohort analysis of the ProActive trial. Diabetologia 51:787–794PubMedCentralCrossRefPubMed
35.
go back to reference Helmerhorst HJF, Wijndaele K, Brage S et al (2009) Objectively measured sedentary time may predict insulin resistance independent of moderate- and vigorous-intensity physical activity. Diabetes 58:1776–1779PubMedCentralCrossRefPubMed Helmerhorst HJF, Wijndaele K, Brage S et al (2009) Objectively measured sedentary time may predict insulin resistance independent of moderate- and vigorous-intensity physical activity. Diabetes 58:1776–1779PubMedCentralCrossRefPubMed
36.
go back to reference Wijndaele K, Orrow G, Ekelund U et al (2014) Increasing objectively measured sedentary time increases clustered cardiometabolic risk: a 6 year analysis of the ProActive study. Diabetologia 57:305–312PubMedCentralCrossRefPubMed Wijndaele K, Orrow G, Ekelund U et al (2014) Increasing objectively measured sedentary time increases clustered cardiometabolic risk: a 6 year analysis of the ProActive study. Diabetologia 57:305–312PubMedCentralCrossRefPubMed
37.
go back to reference Yates T, Haffner SM, Schulte PJ et al (2014) Association between change in daily ambulatory activity and cardiovascular events in people with impaired glucose tolerance (NAVIGATOR trial): a cohort analysis. Lancet 383:1059–1066CrossRefPubMed Yates T, Haffner SM, Schulte PJ et al (2014) Association between change in daily ambulatory activity and cardiovascular events in people with impaired glucose tolerance (NAVIGATOR trial): a cohort analysis. Lancet 383:1059–1066CrossRefPubMed
38.
go back to reference Lahjibi E, Heude B, Dekker JM et al (2013) Impact of objectively measured sedentary behaviour on changes in insulin resistance and secretion over 3 years in the RISC study: interaction with weight gain. Diabetes Metab 39:217–225CrossRefPubMed Lahjibi E, Heude B, Dekker JM et al (2013) Impact of objectively measured sedentary behaviour on changes in insulin resistance and secretion over 3 years in the RISC study: interaction with weight gain. Diabetes Metab 39:217–225CrossRefPubMed
39.
40.
Metadata
Title
Prospective associations between sedentary time, physical activity, fitness and cardiometabolic risk factors in people with type 2 diabetes
Authors
Maxine J. E. Lamb
Kate Westgate
Søren Brage
Ulf Ekelund
Gráinne H. Long
Simon J. Griffin
Rebecca K. Simmons
Andrew J. M. Cooper
on behalf of the ADDITION-Plus study team
Publication date
01-01-2016
Publisher
Springer Berlin Heidelberg
Published in
Diabetologia / Issue 1/2016
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-015-3756-8

Other articles of this Issue 1/2016

Diabetologia 1/2016 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.